Clofenciclan

Structural formula
General
Non-proprietary name	Clofenciclan
other names	2- [1- (4-chlorophenyl) cyclohexyl] oxy- N , N -diethylethanamine ( IUPAC )
Molecular formula	C 18 H 28 ClNO
External identifiers / databases
PubChem	25904
Wikidata	Q1102163
Drug information
Drug class	stimulant
properties
Molar mass	309.87 g mol −1
Physical state	firmly
Melting point	145–146 ° C ( hydrochloride )
boiling point	145–152 ° C (1.1 h Pa )
safety instructions
GHS hazard labeling ; no classification available
GHS hazard labeling ; no classification available
Toxicological data	142 mg kg −1 ( LD 50 , mouse , ip )
	As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Clofenciclan (also: Chlorphencyclan , Tonquil ) is a drug that was registered as a US patent in 1998. Treatment of drug and alcohol addiction was given as an indication .

In the European Union and Switzerland, Clofenciclan is exempt from customs duties.

literature

W. Poeldinger: Therapeutic experiences with thiopropazate and with a combination of thiopropazate and chlorphencyclan (Vesitan) in psychiatry. In: Praxis (Jan 18/1962), pp. 73-78, PMID 14487367

Individual evidence

↑ ^a ^b Entry on Clofenciclan. In: Römpp Online . Georg Thieme Verlag, accessed on December 29, 2014.
↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
↑ Entry on Clofenciclan in the ChemIDplus database of the United States National Library of Medicine (NLM) .
↑ Patent US5824684 : Method for treating drug and alcohol addiction. Published October 20, 1998 , inventor: Norman Viner. ‌
↑ Regulation (EC) No. 578/2002 of the Commission of March 20, 2002 amending Annex I of Council Regulation (EEC) No. 2658/87 on the tariff and statistical nomenclature and the common customs tariff , accessed on June 20 2017 .
↑ Agreement on the trade in pharmaceutical substances to which duty-free applies, Annex I. (PDF; 1.9 MB) FCA , March 1, 2014, accessed on June 20, 2017 .

[roempp-1] Entry on Clofenciclan. In: Römpp Online . Georg Thieme Verlag, accessed on December 29, 2014.

[NV-2] This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.

[3] Entry on Clofenciclan in the ChemIDplus database of the United States National Library of Medicine (NLM) .

[4] Patent US5824684 : Method for treating drug and alcohol addiction. Published October 20, 1998 , inventor: Norman Viner. ‌

[5] Regulation (EC) No. 578/2002 of the Commission of March 20, 2002 amending Annex I of Council Regulation (EEC) No. 2658/87 on the tariff and statistical nomenclature and the common customs tariff , accessed on June 20 2017 .

[6] Agreement on the trade in pharmaceutical substances to which duty-free applies, Annex I. (PDF; 1.9 MB) FCA , March 1, 2014, accessed on June 20, 2017 .